The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.
Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.
Avastin in Ontario, Canada
kimby
CSN Member Posts: 797 Member
I saw this on another message board I frequent. If you are in Ontario this is really important! Time to be an advocate!
LN posted:
Ontario Ombudsman Andre Marin has launched an investigation into the provincial Ministry of Health and Long-Term Care's funding of Avastin, a drug for colon cancer patients. The province's funding of Avastin is limited to 16 two-week cycles, regardless of patient response to the treatment. The Ombudsman is investigating whether the Ministry's decision to limit funding in this way was informed and reasonable.
The investigation will be conducted by the Special Ombudsman Response Team (SORT), the group of investigators responsible for major systemic investigations, such as the Ombudsman's recent probes into the lottery system, property taxation, newborn screening and the Special Investigations Unit.
SORT will conduct interviews with affected parties and review Ministry documentation relevant to the decision. Anyone with information relevant to the investigation may call the Ombudsman's complaint line at 1-800-263-1830.
Aussi disponible en francais
On the Web: www.ombudsman.on.ca
LN posted:
Ontario Ombudsman Andre Marin has launched an investigation into the provincial Ministry of Health and Long-Term Care's funding of Avastin, a drug for colon cancer patients. The province's funding of Avastin is limited to 16 two-week cycles, regardless of patient response to the treatment. The Ombudsman is investigating whether the Ministry's decision to limit funding in this way was informed and reasonable.
The investigation will be conducted by the Special Ombudsman Response Team (SORT), the group of investigators responsible for major systemic investigations, such as the Ombudsman's recent probes into the lottery system, property taxation, newborn screening and the Special Investigations Unit.
SORT will conduct interviews with affected parties and review Ministry documentation relevant to the decision. Anyone with information relevant to the investigation may call the Ombudsman's complaint line at 1-800-263-1830.
Aussi disponible en francais
On the Web: www.ombudsman.on.ca
Discussion Boards
- All Discussion Boards
- 7 Cancer Survivors Network Information
- 6 Welcome to CSN
- 1 CSN Update
- 122.7K Cancer specific
- 2.8K Anal Cancer
- 457 Bladder Cancer
- 311 Bone Cancers
- 1.7K Brain Cancer
- 28.6K Breast Cancer
- 410 Childhood Cancers
- 28K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13.1K Head and Neck Cancer
- 6.4K Kidney Cancer
- 682 Leukemia
- 805 Liver Cancer
- 4.2K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 243 Multiple Myeloma
- 7.2K Ovarian Cancer
- 71 Pancreatic Cancer
- 493 Peritoneal Cancer
- 5.7K Prostate Cancer
- 1.2K Rare and Other Cancers
- 544 Sarcoma
- 745 Skin Cancer
- 663 Stomach Cancer
- 194 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.5K Lifestyle Discussion Boards